Taking place on 5 July: New concepts in COPD

Taking place on 5 July, this ERS Vision Live panel discussion will focus on new concepts in chronic obstructive pulmonary disease (COPD).
The expert panellists will discuss key areas, including:
Pharmacological management of COPD
Role of eosinophils as biomarkers in COPD
Pre-COPD, PRISm and early/young COPD
This event is free to access but registration is required.
Chairs: Alvar Agustí, Marta Drummond.
Speakers: Speakers: Prof. Dave Singh, Prof. Dr Claus Vogelmeier, Dr MeiLan Han
Date: 5 July, 2023 | 18:00–19:00 CEST
Fuente de la información en este link, donde también puedes apuntarte: https://www.ersnet.org/events/new-concepts-in-copd/#ProfMartaDrummond
Noticias relacionadas

Falling through the cracks: what happens to survivors of preterm birth?
Survivors of preterm birth face increased risks of respiratory diseases, yet awareness among specialists is low. This study examines gaps in long-term care, highlighting the need for clear follow-up guidelines and improved communication between medical teams.

Artificial Intelligence in COPD
Artificial Intelligence in COPD is transforming disease management, from underdiagnosis to treatment guidance. Discover how machine learning clusters patients, predicts outcomes, and optimizes healthcare resources.

Fractional exhaled nitric oxide in a respiratory healthy general population through the lifespan
Discover the normal ranges of fractional exhaled nitric oxide (FeNO) across different age groups in a respiratory healthy population. Based on 2,251 participants, this study identifies factors like age, body height, and eosinophil counts that influence FeNO levels.
Más artículos
Últimos artículos
- 759397·Alberto Sandiumenge et Al.-Systemic Inflammation Differences in Brain-vs. Circulatory-Dead Donors: Impact on Lung Transplant Recipients
- 769385·GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee
- 778987·Shyamali C Dharmage, et al. Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study.
- 779175·José Luis Izquierdo, José Miguel Rodríguez, Carlos Almonacid, María Benavent, Ramón Arroyo-Espliguero, Alvar Agustí – Real-life burden of hospitalisations due to COPD exacerbations in Spain
- 779279·Alvar Agustí, Eleni Rapsomaniki, Richard Beasley, Rod Hughes, Hana Müllerová, Alberto Papi,Ian D. Pavord, Maarten van den Berge, Rosa Faner – Treatable traits in the NOVELTY study1. 2022
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría EPOC en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida mediante capturas en el documento enlazado en la parte pública del artículo en (https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00302-2/fulltext) : https://www.healthdata.org/sites/default/files/files/policy_report/2019/GBD_2017_Booklet.pdf